Viracta Therapeutics Inc (VIRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -18,043 | -12,101 | -5,860 | -26,615 | -20,618 |
| Depreciation Amortization | 118 | 111 | 44 | 201 | 150 |
| Accounts payable and accrued liabilities | -623 | -701 | -532 | -304 | -420 |
| Other Working Capital | -1,788 | -1,828 | -714 | -627 | 385 |
| Other Operating Activity | 1,899 | 1,512 | 949 | 2,941 | 2,605 |
| Operating Cash Flow | $-18,437 | $-13,007 | $-6,113 | $-24,404 | $-17,898 |
| Cash Flows From Investing Activities | |||||
| Purchase Of Investment | -13,080 | -2,386 | 0 | N/A | 0 |
| Sale Of Investment | N/A | N/A | 0 | 4,780 | 4,780 |
| Investing Cash Flow | $-13,080 | $-2,386 | $0 | $4,780 | $4,780 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 5,453 | 5,453 | N/A | N/A | 0 |
| Common Stock Issued | 32,568 | 11,162 | 10,690 | 6,343 | 6,303 |
| Other Financing Activity | 5,033 | 379 | 6,538 | 0 | 0 |
| Financing Cash Flow | $43,054 | $16,994 | $17,228 | $6,343 | $6,303 |
| Beginning Cash Position | 13,696 | 13,696 | 13,696 | 26,977 | 26,977 |
| End Cash Position | 25,233 | 15,297 | 24,811 | 13,696 | 20,162 |
| Net Cash Flow | $11,537 | $1,601 | $11,115 | $-13,281 | $-6,815 |
| Free Cash Flow | |||||
| Operating Cash Flow | -18,437 | -13,007 | -6,113 | -24,404 | -17,898 |
| Free Cash Flow | -18,437 | -13,007 | -6,113 | -24,404 | -17,898 |